NFKB1 and COVID-19: The central role of the NF-κB pathway in COVID-19 may therefore partially explain the severest disease phenotype experienced by elderly and by patients affected by comorbidities such as obesity and diabetes characterized by chronic NF-κB upregulation (Kircheis et al., 2021).